FDA Approves First mRNA Flu Shot After Initial Rejection
The Food and Drug Administration has approved the first-ever mRNA-based flu vaccine for adults aged 50 and older, despite trial data showing it produces severe, incapacitating side effects at more than six times the rate of traditional flu shots while preventing only one additional hospitalization per 5,000 doses. The approval has sparked fierce debate about … Continued